Observational studyRheumatology international2023

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab.

Katarzyna Łosińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.